Israel Englander Novo Cure LTD Call Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $4.68 Million - $7 Million	300,000 New	300,000 $4.69 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $2.16 Million - $3.06 Million	-194,100 Reduced 93.36%	13,800 $206,000
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $8.38 Million - $17.2 Million	207,900 New	207,900 $8.63 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $1.41 Million - $1.88 Million	22,000 New	22,000 $1.61 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.